-46.2%
QXO vs EMR
+62.0%
-108.2%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | +2.6% | -2.4% | -1.2% |
| 7D | -7.8% | -0.4% | -7.4% | -7.6% |
| 30D | -18.1% | -6.8% | -11.3% | -15.0% |
| 3M | -25.8% | +7.5% | -33.2% | -28.0% |
| 6M | -41.7% | +9.9% | -51.6% | -43.8% |
| YTD | -36.2% | +16.0% | -52.2% | -39.3% |
| 1Y | -42.1% | +12.4% | -54.5% | -44.6% |
| 3Y | -46.2% | +60.2% | -106.4% | -36.0% |
| All | -46.2% | +62.0% | -108.2% | -36.0% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling